Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Re-cellf RiCarna Clinic is a Tokyo-based medical facility specializing in regenerative medicine and advanced cell therapies. The clinic offers autologous adipose-derived stem cell (ADSC) treatments and exosome-based therapies designed to address chronic conditions such as osteoarthritis and diabetes, as well as aesthetic concerns like hair loss and skin aging. By utilizing specialized cell processing techniques, the clinic provides personalized medical interventions aimed at tissue repair and reducing systemic inflammation. Re-cellf RiCarna Clinic operates at the intersection of clinical practice and biotechnology, applying cutting-edge regenerative research to patient care. Its services are centered on the RICARNA brand of regenerative solutions, emphasizing safety and efficacy in autologous transplantation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Re-cellf RiCarna Clinic.